El Mahdiui, Mohammed
Smit, Jeff M.
van Rosendael, Alexander R.
Neglia, Danilo
Knuuti, Juhani
Saraste, Antti
Buechel, Ronny R.
Teresinska, Anna
Pizzi, Maria N.
Roque, Albert
Magnacca, Massimo
Mertens, Bart J.
Caselli, Chiara
Rocchiccioli, Silvia
Parodi, Oberdan
Pelosi, Gualtiero
Scholte, Arthur J.
Funding for this research was provided by:
Horizon 2020 Framework Programme (GA number: 689068)
Article History
Received: 12 November 2020
Accepted: 22 February 2021
First Online: 10 March 2021
Declarations
:
: The department of Cardiology of Leiden University Medical Center received unrestricted research grants from Abbott Vascular, Bayer, Bioventrix, Biotronik, Boston Scientific, Edwards Lifesciences, GE Healthcare and Medtronic. The University Hospital Zurich holds a research agreement with GE Healthcare. Ronny R. Buechel reports receiving speaker honoraria from GE Healthcare. J. Knuuti discloses speaker fees from GE Healthcare, Merck, Lundbeck and Bayer and study protocol consultancy fees from GE Healthcare and AstraZeneca outside of submitted work.
: The study protocol was submitted to the Ethics Committe CEAVNO, Comitato Etico Sperimentazione Clinica Area Vasta Nord-Ovest (Pisa, Italy) and approved by letter. n. 23534 of 14/04/2016. The study protocol was approved by all local ethical committees and all patients gave their written informed consent to participate in the study. (ClinicalTrials.gov number, NCT04448691.)